Hompland, I. et al. 2024. Discontinuation of imatinib in patients with oligometastatic gastrointestinal stromal tumour who are in complete radiological remission: a prospective multicentre phase II study. Acta Oncologica. 63, 1 (May 2024), 288–293. DOI:https://doi.org/10.2340/1651-226X.2024.39851.